NIFTY, Intraday Tips, NSE, News, Mutual Fund, Commodity, Currency, World Market, Finance, Economic, BSE, Wealth, NPS, IPO, Portfolio, MCX, Investment Guru

02-03-2021 02:02 PM | Source: Angel Broking Ltd

Quote On Ajanta Pharma 3QFY21 By Yash Gupta, Angel Broking

News By Tags | #1465 #5948 #607 #6174

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Below are Quote On Ajanta Pharma 3QFY21 By Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd

Ajanta Pharma reported numbers better than the expectation, stock up by 5%. Ajanta Pharma limited total revenue from operations for Q3FY21 stood at ₹749 crores up by 15% YoY from ₹651 crores in Q3FY20. EBITDA for Q3FY21 stood at ₹242 crores up by 30% as compared to ₹186 crores in Q3FY20. Profit before tax for the quarter at ₹crores in Q3FY21 as compared to loss of ₹527.4 crores in Q3FY20. Profit after tax for the quarter up by 64% at ₹177 crores in Q3FY21 as compared to ₹108 crores in Q3FY20. Indian business has done very well for the company, reported revenue growth of 13%, while USA generic business up by 1% only. Company reported EBITDA margins at 32% which are better than expectations. We have a positive outlook towards Ajanta Pharma limited.

Above views are of the author and not of the website kindly read disclaimer

IGI Logo

Quote On Ajanta Pharma 3QFY21 By Yash Gupta, Angel Broking

Top News

Tag News

More News